Combination Therapy of Pyrotinib and Metronomic Vinorelbine in HER2+ Advanced Breast Cancer after Trastuzumab Failure (PROVE): A Prospective Phase 2 Study.
Saved in:
| Title: | Combination Therapy of Pyrotinib and Metronomic Vinorelbine in HER2+ Advanced Breast Cancer after Trastuzumab Failure (PROVE): A Prospective Phase 2 Study. |
|---|---|
| Authors: | Hao, Chunfang1,2,3 (AUTHOR) haochunfang@tjmuch.com, Wang, Xu1,2 (AUTHOR), Shi, Yehui1,2 (AUTHOR), Tong, Zhongsheng1,2 (AUTHOR), Li, Shufen1,2 (AUTHOR), Liu, Xiaodong1,2 (AUTHOR), Zhang, Lan1,2 (AUTHOR), Zhang, Jie3 (AUTHOR), Meng, Wenjing1,2 (AUTHOR), Zhang, Li1,2 (AUTHOR) |
| Source: | Cancer Research & Treatment. Apr2025, Vol. 57 Issue 2, p434-442. 9p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 185203919 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Combination Therapy of Pyrotinib and Metronomic Vinorelbine in HER2+ Advanced Breast Cancer after Trastuzumab Failure (PROVE): A Prospective Phase 2 Study. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Hao%2C+Chunfang%22">Hao, Chunfang</searchLink><relatesTo>1,2,3</relatesTo> (AUTHOR)<i> haochunfang@tjmuch.com</i><br /><searchLink fieldCode="AR" term="%22Wang%2C+Xu%22">Wang, Xu</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Shi%2C+Yehui%22">Shi, Yehui</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Tong%2C+Zhongsheng%22">Tong, Zhongsheng</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Li%2C+Shufen%22">Li, Shufen</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Liu%2C+Xiaodong%22">Liu, Xiaodong</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zhang%2C+Lan%22">Zhang, Lan</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zhang%2C+Jie%22">Zhang, Jie</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Meng%2C+Wenjing%22">Meng, Wenjing</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zhang%2C+Li%22">Zhang, Li</searchLink><relatesTo>1,2</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Cancer+Research+%26+Treatment%22">Cancer Research & Treatment</searchLink>. Apr2025, Vol. 57 Issue 2, p434-442. 9p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=185203919 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.4143/crt.2024.340 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 9 StartPage: 434 Titles: – TitleFull: Combination Therapy of Pyrotinib and Metronomic Vinorelbine in HER2+ Advanced Breast Cancer after Trastuzumab Failure (PROVE): A Prospective Phase 2 Study. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Hao, Chunfang – PersonEntity: Name: NameFull: Wang, Xu – PersonEntity: Name: NameFull: Shi, Yehui – PersonEntity: Name: NameFull: Tong, Zhongsheng – PersonEntity: Name: NameFull: Li, Shufen – PersonEntity: Name: NameFull: Liu, Xiaodong – PersonEntity: Name: NameFull: Zhang, Lan – PersonEntity: Name: NameFull: Zhang, Jie – PersonEntity: Name: NameFull: Meng, Wenjing – PersonEntity: Name: NameFull: Zhang, Li IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 04 Text: Apr2025 Type: published Y: 2025 Identifiers: – Type: issn-print Value: 15982998 Numbering: – Type: volume Value: 57 – Type: issue Value: 2 Titles: – TitleFull: Cancer Research & Treatment Type: main |
| ResultId | 1 |